Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study To Investigate The Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatic Subjects

NCT00535431 is registered in ClinicalTrials.gov with Aerovance, Inc. as lead sponsor.

NCT NCT00535431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00535431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study To Investigate The Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatic Subjects
Lead sponsor
Aerovance, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
October 31, 2006
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma